| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 0.3 | 0.1 | 0.1 |
| Total income | 0.3 | 0.1 | 0.1 |
| Profit before exceptional items & tax | -0.1 | -0.0 | 0.0 |
| Profit before tax | -0.1 | -0.0 | 0.0 |
| Net profit | -0.2 | -0.0 | 0.0 |
| Operating margin | -33.3% | 0.0% | 0.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Revenue, year on year | +200.00% |
|---|
BSE results filing, NSE: PRISMMEDI. Figures extracted from the filing.
Prism Medico and Pharmacy Ltd: key numbers
- Share price
- ₹28.83
- Market cap
- ₹39.10 Cr
- Revenue (annual)
- ₹2.44 Cr
- Net profit (annual)
- ₹0.32 Cr
- P/E (TTM)
- -98.4×Sector 41.4×
- Promoter holding
- 29.98%+4.49% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Prism Medico and Pharmacy Ltd
All →Prism Medico and Pharmacy Management Change
Prism Medico and Pharmacy Limited re-appointed Davender Singh as a Non-Executive Non-Independent Director. The company also updated its statutory and secretarial auditor appointments.
Prism Medico and Pharmacy Annual General Meeting
Prism Medico and Pharmacy held its 24th Annual General Meeting on September 19, 2026, to transact ordinary and special business, including various investment approvals.
Prism Medico and Pharmacy Q1 FY27 Results: Net Loss of ₹0.1 Cr
Prism Medico and Pharmacy Ltd reported a net loss of ₹0.1 Cr for Q1 FY27.
- Key figure
- Net loss ₹0.1 Cr